VIRTUAL PSYCHEDELICS CONFERENCE
In the midst of a global health crisis, Microdose and The Conscious Fund are hosting a worldwide virtual conference for the emerging psychedelic medicine industry, the biggest global event in the space to date. Given the mental health and wellbeing challenges facing the world, the conference is a timely look at the new treatments and therapies which have astonished researchers.
In partnership with The Green Light and TCF, a venture capital fund with active investments in the psychedelics industry, this groundbreaking event will bring together CEOs, investors, scientists, researchers, and regulators for an array of panel discussions and collaborative networking.
Psychedelic drugs are showing incredible promise in their ability to treat a vast range of mental health conditions, including addiction, treatment-resistant depression, PTSD, eating disorders, and many more. Forward thinking scientists, a new breed of psychedelic medicine companies and healthcare advocates are learning to harness the power of psychedelics to tackle the worldwide need for mental wellbeing head-on.
Using new virtual conferencing software, attendees will have access to leading psychedelic experts, and discover the latest trends, while building bridges with thought-leaders and exploring unique investment opportunities.
The conference agenda includes a briefing to set the scene on the psychedelics industry, followed by discussions on psychedelic medicine, drug development, regulation and investment. One to one and group discussions will take place throughout the event.
All times are GMT.
5:00pm – 5:15pm – Opening Remarks
5:15pm – 5:45pm – Psychedelics: Setting the Scene
5:45pm – 6:15pm – Psychedelic Medicine: A New Frontier
6:15pm – 6:45pm – The Pathway to Commercialisation: Drug Development & Regulation
6:45pm – 7:15pm – The Psychedelic Investment Landscape
7:15pm – 7:30pm – Closing Remarks
7:30pm – 9:00pm – 1-on-1 Meetings
Leveraging our global network, we have confirmed speaker slots with some of the leading scientists, researchers and CEOs in the psychedelics industry.
Look out for speaker announcements over the coming days and weeks!
Exclusive Investor Briefings
For Premium ticket-holders, 1-on-1 meetings are a chance to meet active investors pursuing opportunities in the space. Pairing decades of venture capital expertise, our team will ensure pairings are relevant and useful.
Premium ticket holders can select one of the following categories to be paired with:
- Psychedelics Companies
TCF will choose the pairing and leave the two parties to schedule the call at the end of the conference. All speakers and sponsors will agree to participate in 1-on-1s by virtue of their involvement.
Our sponsors are an exclusive group of industry leaders and start-ups, who are selected to present and showcase their companies to our diverse network of investors, including UHNWIs, Family Offices, VCs, PEs and other Funds.
Selected sponsors have the unique opportunity to gain access to our full digital marketing and PR suite, placing their brand in front of 110,000+ customers, decision-makers and influencers.
Leading sponsors will also have the opportunity to personally connect with investors and multinational corporates through 1-on-1 investor briefings.
We have held several Investment Summits across Europe, including London, Malta and Luxembourg. We have hosted 300+ investors and international cannabis and psychedelics companies. Investors including UHNWIs, Family Offices, and VCs with a combined AUM of €15bn+ attended our events to meet founders and source investment opportunities.
All tickets are offered on a first-come first-served basis.
If you are an accredited member of the press, please contact us.
Hive is at the forefront of the European psychedelic medicine revolution, a unique blend of scientific research and patient therapeutics. It is open to qualifying investors and strategic partners only. Please visit www.hive.bio to register your interest.